We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Women's Treatment for Trauma and Substance Use Disorders - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00078156
First Posted: February 23, 2004
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Institute on Drug Abuse (NIDA)
  Purpose
The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard substance abuse treatment.

Condition Intervention Phase
Substance-Related Disorders Behavioral: Behavior Therapy Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Women's Treatment for Trauma and Substance Use Disorders

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Drug abstinence

Estimated Enrollment: 409
Study Start Date: January 2004
Estimated Study Completion Date: October 2005
Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria - Women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD.

Exclusion Criteria:

- Women will be excluded from the study who have current psychotic disorders, or a history of active psychosis (past two months); women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD; and women who have current psychotic disorders, or a history of active psychosis (past two months).

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00078156


Locations
United States, Florida
Gateway Community Services
Jacksonville, Florida, United States, 32224
The Villiage
Miami, Florida, United States, 33137
United States, New York
Addiction Research & Treatment Corp.-MSUCAS
Brooklyn, New York, United States, 11238
Addiction Research & Treatment Corp.-RISE
Brooklyn, New York, United States, 11238
United States, Ohio
Maryhaven, Inc.
Columbus, Ohio, United States, 43207
United States, South Carolina
Charleston Center
Charleston, South Carolina, United States, 29403
United States, Washington
Residence XII
Kirkland, Washington, United States, 98034
Sponsors and Collaborators
New York State Psychiatric Institute
Investigators
Principal Investigator: Denise Hien, Ph.D. New York State Psychiatric Institute
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Denise Hien, Ph.D., New York State Psychiatric Institute
ClinicalTrials.gov Identifier: NCT00078156     History of Changes
Other Study ID Numbers: NIDA-CTN-0015-1
First Submitted: February 19, 2004
First Posted: February 23, 2004
Last Update Posted: January 12, 2017
Last Verified: October 2016

Keywords provided by National Institute on Drug Abuse (NIDA):
behavioral intervention

Additional relevant MeSH terms:
Disease
Substance-Related Disorders
Pathologic Processes
Chemically-Induced Disorders
Mental Disorders